Current Management of the MenopauseChristian Lauritzen, John W. W. Studd CRC Press, 22 de juny 2005 - 506 pàgines In the next few decades, an estimated one billion women will reach menopause. They will depend on the preventative measures, management, and advice provided to them by their gynecologist or general practitioner. At a time when doubts and criticisms have been raised concerning the real benefit and the justification of peri- to postmenopausal estroge |
Continguts
1 Basic Facts and Definitions | 2 |
2 Social Structure and Social Medicine | 11 |
3 Menopausal changes of ovaries and hypothalamicpituitary and cerebral function | 24 |
4 Premenopausal Cycle Anomalies | 38 |
5 History of EstrogenProgestogen Replacement Therapy | 43 |
6 The Awareness of the Menopausal Woman Concerning the Menopausal Transition | 51 |
7 The Considerations Hopes and Fears of the Menopausal Woman | 60 |
8 The Climacteric Syndrome | 64 |
18 Sexuality in Postmenopause and Senium | 230 |
19 Estrogens and Urogenital Atrophy | 256 |
20 Estrogens in the Treatment of Premenstrual Postnatal and Perimenopausal Depression | 274 |
21 Antiaging and Esthetic Endocrinology | 285 |
22 Skin and Connective Tissue | 303 |
23 Lifestyle Counseling | 313 |
24 Phytoestrogens | 338 |
Venous Thromboembolism VTE | 354 |
9 Practice of Hormone Substitution | 93 |
10 Mechanisms of Action of Sex Steroid Hormones and their Analogs | 109 |
11 Estrogens Progestogens and the Endometrium | 129 |
Effects on Glucose and Insulin Metabolism and the Metabolic Syndrome | 144 |
13 Possible Sideeffects of Sexual Hormones | 162 |
14 Osteoporosis | 172 |
15 Hormone Replacement Therapy and Atherosclerotic Vascular Disease | 187 |
16 Direct Vascular Actions of Estrogens | 197 |
Implications for Alzheimers Disease | 215 |
26 Gallbladder Liver Pancreas | 362 |
Promotion and Prevention | 373 |
28 Strategies for the Prevention of Breast and Gynecologic Cancer | 390 |
29 Benefits Risks and Costs of Estrogen and Hormone Replacement Therapies | 432 |
30 Information Sheet for Climacteric Women | 482 |
31 The Aging Male | 492 |
32 Future Developments | 520 |
| 538 | |
Altres edicions - Mostra-ho tot
Current Management of the Menopause Christian Lauritzen,John W. W. Studd Previsualització no disponible - 2005 |
Frases i termes més freqüents
acid activity addition androgen associated benefits body bone breast cancer cardiovascular cause cells changes climacteric Clin clinical collagen combined compared complaints concentrations considered continuous controlled coronary costs decrease depression diabetes disease disorders dose early effects endometrial cancer estradiol estrogen et al expectancy factors female flushes fractures function genistein glucose heart higher hormone replacement therapy human important improvement incidence increase indicated individual influence insulin intake leading levels long-term loss lower measures menopause metabolism months mortality myocardial infarction normal observed Obstet Gynecol occur oral osteoporosis ovarian patients physical phytoestrogens possible postmenopausal women prevention problems production progesterone progestogen protein randomized recent receptor reduced relative reported response risk role serum sexual showed shown significant skin steroid substitution symptoms syndrome Table tissue transdermal treatment trial urinary urogenital vaginal vitamin woman